Oncotarget

Vol 10, No 29

April 19, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 29 of Oncotarget features Figure 6, "RIL + RT reduces anchorage-independent colony growth of glioma cells," by Khan, et al.

Table of Contents

Editorial

Guidelines and tumor boards are required for solid organ recipients with de novo carcinoma

Guidelines and tumor boards are required for solid organ recipients with de novo carcinoma

https://doi.org/10.18632/oncotarget.26860

Benoit Rousseau, Aude Guillemin,  and Christophe Tournigand
2789-2790
PDF  |  Order a Reprint

Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial

Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial

https://doi.org/10.18632/oncotarget.26870

Federica Marmorino, Alfredo Falcone,  and Chiara Cremolini
2791-2792
PDF  |  Order a Reprint

Research Papers

PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells

PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells

https://doi.org/10.18632/oncotarget.26876

Fabiola Cervantes-Gomez, Christine M. Stellrecht, Mary L. Ayres, Michael J. Keating, William G. Wierda,  and Varsha Gandhi
2793-2809
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules

Tumor-infiltrating mucosal-associated invariant T (MAIT) cells retain expression of cytotoxic effector molecules

https://doi.org/10.18632/oncotarget.26866

Patrik Sundström, Louis Szeponik, Filip Ahlmanner, Malin Sundquist, Justin S.B. Wong, Elinor Bexe Lindskog, Bengt Gustafsson,  and Marianne Quiding-Järbrink
2810-2823
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo

The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo

https://doi.org/10.18632/oncotarget.26854

Atif J. Khan, Stephanie LaCava, Monal Mehta, Devora Schiff, Aditya Thandoni, Sachin Jhawar, Shabbar Danish, Bruce G. Haffty,  and Suzie Chen
2824-2834
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes

MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes

https://doi.org/10.18632/oncotarget.26838

Maria M. Simile, Graziella Peitta, Maria L. Tomasi, Stefania Brozzetti, Claudio F. Feo, Alberto Porcu, Antonio Cigliano, Diego F. Calvisi, Francesco Feo,  and Rosa M. Pascale
2835-2854
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC